Medicare Cancer Rx Payments Will Be “Disastrous,” Ex-ASCO Head Warns

Oncology drug reimbursement changes mandated by the 2003 Medicare Rx law will cause long term damage to patient care, Memorial Sloan-Kettering Director of Breast Cancer Programs Larry Norton, MD, said June 22 at a Newsweek/Coalition of National Cancer Cooperative Groups panel in Washington, D.C